Amundi Asset Management US’s Myriad Genetics MYGN Stock Holding History

Amundi Asset Management US’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$4.14M	Buy	+136,000	New	+$3.86M	﹤0.01%	1055
2020 Q2	–	Sell	-7,000	Closed	-$100K	–	1663
2020 Q1	$100K	Hold	7,000	–	–	﹤0.01%	1434
2019 Q4	$191K	Hold	7,000	–	–	﹤0.01%	1486
2019 Q3	$200K	Buy	7,000 +1,500	+27%	+$43.7K	﹤0.01%	1457
2019 Q2	$153K	Hold	5,500	–	–	﹤0.01%	1515
2019 Q1	$183K	Buy	+5,500	New	+$167K	﹤0.01%	1452
2018 Q4	–	Sell	-15,400	Closed	-$708K	–	1646
2018 Q3	$708K	Buy	+15,400	New	+$685K	﹤0.01%	1309

Other funds holding MYGN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return